Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Metastatic gpNMB Expressing Triple Negative Breast Cancer × glembatumumab vedotin × Clear all

Status

No longer available 1

Sponsor Class

Study Type

Expanded_access 1

Sponsor

Cancer Type

Conditions

Triple Negative Breast Neoplasms 3 Breast Neoplasms 3 Uveal Melanoma 2 Melanoma 2 Squamous Cell Carcinoma of the Lung 1 Skin Neoplasms 1 Osteosarcoma 1 Neoplasm Metastasis 1 Metastatic gpNMB Expressing Triple Negative Breast Cancer 1

Interventions

glembatumumab vedotin 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03067935 2018-05-21

Individual Patient Expanded Access-Glembatumumab Vedotin

Celldex Therapeutics

No longer available

Metastatic gpNMB Expressing Triple Negative Breast Cancer

Data powered by HemOnc (CC BY 4.0) Colophon ⚡